(Q68892301)
Statements
A new approach to the therapy of cancer based on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 (English)
Rosenberg SA
Muul LM
Leitman S
Chang AE
Vetto JT
Seipp CA
1 August 1986